Sign inJoin waitlistJoin the waitlist

Rusha Bhandari

Pediatric Hematologist-Oncologist · City of Hope National Medical Center

Credentials: · · · · · ·

History

City of Hope National Medical Center
Present

Pediatric Hematology-Oncology
2017–2018
Pediatrics
Washington University/B-JH/SLCH Consortium
2014–2017
Doctor of Medicine
2010–2014

Research

Interventions to Improve HPV Vaccine Uptake: A Systematic Review
Systematic review or meta-analysis · PEDIATRICS · 2016 · 204 citations
The role of nutrition and diet in Alzheimer disease: a systematic review
Systematic review or meta-analysis · Journal of the American Medical Directors Association · 2013 · Sole author · 86 citations
Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges
Review · Journal of the National Cancer Institute. Monographs · 2023 · 33 citations

SA
Saro Armenian
17 papers
Ryotaro Nakamura
6 papers
Stephen Forman
6 papers
June-Wha Rhee
5 papers
AH
Alex Herrera
4 papers
Andrew Artz
4 papers
Etan Orgel
4 papers
MM
Matthew Mei
4 papers
Shana McCormack
3 papers
Sogol Mostoufi-Moab
3 papers
Sonata Jodele
3 papers
Artem Oganesyan
2 papers · 2 as a resident

Grants

Muscle Health and Impaired Glucose Tolerance in Adolescent and Young Adult Hematopoietic Cell Transplantation Survivors
National Cancer Institute · K08
Contact PI · $280.9K · Beckman Research Institute/City of Hope
2026–2030

Clinical trials

The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
Principal investigator · Active not recruiting
City of Hope Medical Center
2022–2026
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2027